Xeloda and Blood test abnormal - a phase IV clinical study of FDA data
Summary:
Blood test abnormal is reported as a side effect among people who take Xeloda (capecitabine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Kadcyla, and have Pain.
The phase IV clinical study analyzes which people have Blood test abnormal when taking Xeloda. It is created by eHealthMe based on reports of 46,293 people who have side effects when taking Xeloda from the FDA, and is updated regularly.
What is Xeloda?
Xeloda has active ingredients of capecitabine. It is often used in colon cancer. eHealthMe is studying from 46,649 Xeloda users. Check the latest studies of Xeloda.
What is Blood test abnormal?
Blood test abnormal is found to be associated with 837 drugs and 722 conditions by eHealthMe. Check the latest studies of Blood test abnormal.
46,293 people reported to have side effects when taking Xeloda.
Among them, 130 people (0.28%) have Blood test abnormal.

Among these 130 people:
How long have people been on Xeloda when they have Blood test abnormal? *
What is the gender of people who have Blood test abnormal when taking Xeloda? *
What is the age of people who have Blood test abnormal when taking Xeloda? *
What are other drugs people take besides Xeloda? *
What are other side effects people have besides Blood test abnormal? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Xeloda and have Blood test abnormal?
- Check whether Blood test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Xeloda:
- Xeloda (46,649 reports)
Blood test abnormal treatments and more:
- Blood test abnormal (15,862 reports)
How severe was Blood test abnormal and when was it recovered:
Expand to all the drugs that have ingredients of capecitabine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xeloda:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Blood test abnormal:
- Blood test abnormal (837 drugs)
Browse all the conditions that are associated with Blood test abnormal:
- Blood test abnormal (722 conditions)
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on capecitabine (the active ingredients of Xeloda) and Xeloda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lamictal and Neoral - 25 seconds ago
- How effective is Allegra for Seasonal Allergy? - 27 seconds ago
- Could Lamictal Cd cause Tremor? - 49 seconds ago
- Kombiglyze Xr vs. Novorapid, side effect and effectiveness comparison - 53 seconds ago
- Could Adrucil cause Acute Kidney Failure? - a minute ago
- Could Maxalt cause Restless Leg Syndrome? - a minute ago
- Could Amerge cause Stress And Anxiety? - a minute ago
- Drug interactions of Colchicine and Bumetanide - a minute ago
- Drug interactions of Halobetasol Propionate and Protonix - a minute ago
- Drug interactions of Hydroxyurea and Glucosamine - 2 minutes ago